PT  - JOURNAL ARTICLE
AU  - Turner, Charles F.
AU  - Turner, Brett A.
AU  - Chromy, James R.
TI  - Reproducibility of Survey Measurements of Sexual Orientation in the USA
AID  - 10.1101/2022.04.12.22273781
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.12.22273781
4099  - http://medrxiv.org/content/early/2022/04/16/2022.04.12.22273781.short
4100  - http://medrxiv.org/content/early/2022/04/16/2022.04.12.22273781.full
AB  - Survey measurements of sexual orientation have become increasingly common in national population surveys although validation of these measurements is rare and inherently problematic. We instead assess the reproducibility of parallel measurements from two independent samples of the USA population made in the 2008-2018 General Social Surveys and the adult probability subsets of the 2013-2018 National Health Interview Survey (Ns = 12,098 and 190,113).Restricting analysis to the categories gay/lesbian, bisexual, and straight, we obtain similar estimates of the proportion of the U.S. population who consider themselves gay/lesbian (NHIS: 1.59% vs. GSS: 1.93%, p = 0.059) but not bisexual (NHIS: 1.03% vs. GSS: 2.90%, p < 0.001). Fitting multinomial logistic regression models controlling for year, gender, birth cohort, education, and race, we find that compared to the NHIS, the GSS had 1.248 (p=0.022) times higher relative odds of eliciting a response of Gay-Lesbian (vs. Straight) and 2.980 (p<0.001) times higher relative odds of eliciting a response of Bisexual (vs. Straight). Expanding the model by adding 3-way interaction terms for orientation-by-predictor-by-survey, we find that we cannot reject the null hypothesis that trends over time and across subpopulations in reporting of sexual orientation were statistically equivalent for the two survey programs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCFT undertook this work while on sabbatical leave from Queens College, CUNYAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The datasets used in these secondary analyses are publicly available without restriction (https://gss.norc.org/get-the-data and https://nhis.ipums.org/nhis/). As such, these secondary analyses are exempt from IRB review.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used in these secondary analyses are publicly available without restriction (https://gss.norc.org/get-the-data and https://nhis.ipums.org/nhis/). https://gss.norc.org/get-the-data https://nhis.ipums.org/nhis/